Acceptability and Tolerance Study of a Low Calorie Peptide Based Paediatric Tube Feed Formula.
NCT ID: NCT03718208
Last Updated: 2020-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2018-08-08
2019-07-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The acceptability data from 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptability, Gastro Intestinal Tolerance Compliance of a Paediatric Tube-feed Formula Derived From Food for Children
NCT03718195
Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay
NCT02912065
Nutritional Tolerance and Safety of a Tube Feeding Formula in Children
NCT05838495
Acceptability and Tolerance Study of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children
NCT04515940
Acceptability and Tolerance Study of a Plant-based Tube Feed
NCT06209593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The dietitian will determine the feeding regimen on an individual basis and the enteral formula will be provided via a feeding tube. A baseline questionnaire will be completed by the dietitian to ensure eligibility of study, current stool patterns or symptoms and weight at the start of the study.
The parents will complete a week intake chart to monitor how much feed has been consumed each day and a tolerance diary to review gastrointestinal symptoms at the start and end of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Paediatric formula
Each child will receive for a period of seven days. The formula is a food for special medical purposes for use under medical supervision.
The dietitian will determine the feeding regimen on an individual basis and the enteral formula will be provided via a feeding tube. One week intake diary, one week tolerance diary, product intake.
Paediatric Formula
Children will switch over to the low calorie paediatric feed. Intake diaries and tolerance diaries will be completed for one week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paediatric Formula
Children will switch over to the low calorie paediatric feed. Intake diaries and tolerance diaries will be completed for one week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Paediatrics aged 1 year above who require a low calorie feed
* Children with Neurological impairment (NI) who require long term tube feeding
* Patients established on a standard or peptide Enteral formula (no gastrointestinal intolerances on a current formula)
* Willingly given, written, informed consent from patient or parent/guardian.
* Willingly given, written assent (if appropriate).
Exclusion Criteria
* Known food allergies to any ingredients (see ingredients list)
* Patients with significant renal or hepatic impairment
* Participation in another interventional study within 2 weeks of this study.
1 Year
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clare Thornton-Wood, BSc
Role: PRINCIPAL_INVESTIGATOR
Dietitian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Waldron Health Centre
Amersham, , United Kingdom
Alexandra Children's Hospital
Brighton, , United Kingdom
Gorton Clinic
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Low calorie 001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.